Logo image of HURA

TUHURA BIOSCIENCES INC (HURA) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:HURA - US8989201038 - Common Stock

1.98 USD
+0.07 (+3.66%)
Last: 12/4/2025, 4:30:01 PM
1.98 USD
0 (0%)
After Hours: 12/4/2025, 4:30:01 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to HURA. HURA was compared to 534 industry peers in the Biotechnology industry. HURA has a bad profitability rating. Also its financial health evaluation is rather negative. HURA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year HURA has reported negative net income.
In the past year HURA has reported a negative cash flow from operations.
In the past 5 years HURA always reported negative net income.
HURA had a negative operating cash flow in each of the past 5 years.
HURA Yearly Net Income VS EBIT VS OCF VS FCFHURA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

HURA's Return On Assets of -112.19% is on the low side compared to the rest of the industry. HURA is outperformed by 78.09% of its industry peers.
Looking at the Return On Equity, with a value of -199.71%, HURA is doing worse than 66.85% of the companies in the same industry.
Industry RankSector Rank
ROA -112.19%
ROE -199.71%
ROIC N/A
ROA(3y)-224%
ROA(5y)-257.81%
ROE(3y)-832.26%
ROE(5y)-1280.11%
ROIC(3y)N/A
ROIC(5y)N/A
HURA Yearly ROA, ROE, ROICHURA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for HURA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HURA Yearly Profit, Operating, Gross MarginsHURA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for HURA has been reduced compared to 1 year ago.
The number of shares outstanding for HURA has been increased compared to 5 years ago.
There is no outstanding debt for HURA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HURA Yearly Shares OutstandingHURA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
HURA Yearly Total Debt VS Total AssetsHURA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -4.66, we must say that HURA is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -4.66, HURA perfoms like the industry average, outperforming 40.82% of the companies in the same industry.
HURA has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
HURA has a Debt to Equity ratio of 0.02. This is comparable to the rest of the industry: HURA outperforms 42.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -4.66
ROIC/WACCN/A
WACCN/A
HURA Yearly LT Debt VS Equity VS FCFHURA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

2.3 Liquidity

HURA has a Current Ratio of 0.83. This is a bad value and indicates that HURA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.83, HURA is not doing good in the industry: 89.14% of the companies in the same industry are doing better.
A Quick Ratio of 0.83 indicates that HURA may have some problems paying its short term obligations.
HURA has a worse Quick ratio (0.83) than 88.95% of its industry peers.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.83
HURA Yearly Current Assets VS Current LiabilitesHURA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

HURA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 62.78%, which is quite impressive.
EPS 1Y (TTM)62.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 14.93% on average over the next years. This is quite good.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y95.06%
EPS Next 2Y38.91%
EPS Next 3Y24.77%
EPS Next 5Y14.93%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HURA Yearly Revenue VS EstimatesHURA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
HURA Yearly EPS VS EstimatesHURA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -2K -4K -6K -8K -10K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HURA. In the last year negative earnings were reported.
Also next year HURA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HURA Price Earnings VS Forward Price EarningsHURA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HURA Per share dataHURA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8

4.3 Compensation for Growth

HURA's earnings are expected to grow with 24.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.91%
EPS Next 3Y24.77%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HURA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TUHURA BIOSCIENCES INC

NASDAQ:HURA (12/4/2025, 4:30:01 PM)

After market: 1.98 0 (0%)

1.98

+0.07 (+3.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-14 2025-11-14/bmo
Earnings (Next)N/A N/A
Inst Owners12.88%
Inst Owner Change-4.2%
Ins Owners34.73%
Ins Owner ChangeN/A
Market Cap101.49M
Revenue(TTM)N/A
Net Income(TTM)-38.84M
Analysts82.22
Price Target9.75 (392.42%)
Short Float %7.14%
Short Ratio12.71
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)-52.55%
DP-0.01%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-54.8%
Min EPS beat(2)-62.53%
Max EPS beat(2)-47.06%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-15.47%
PT rev (3m)-15.47%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-14.41%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.22
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-9.49
EYN/A
EPS(NY)-0.67
Fwd EYN/A
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS0
BVpS0.38
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -112.19%
ROE -199.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-224%
ROA(5y)-257.81%
ROE(3y)-832.26%
ROE(5y)-1280.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 96.63%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.83
Quick Ratio 0.83
Altman-Z -4.66
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)139.9%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y95.06%
EPS Next 2Y38.91%
EPS Next 3Y24.77%
EPS Next 5Y14.93%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-308.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-3862.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-185287%
OCF growth 3YN/A
OCF growth 5YN/A

TUHURA BIOSCIENCES INC / HURA FAQ

What is the fundamental rating for HURA stock?

ChartMill assigns a fundamental rating of 1 / 10 to HURA.


What is the valuation status of TUHURA BIOSCIENCES INC (HURA) stock?

ChartMill assigns a valuation rating of 1 / 10 to TUHURA BIOSCIENCES INC (HURA). This can be considered as Overvalued.


Can you provide the profitability details for TUHURA BIOSCIENCES INC?

TUHURA BIOSCIENCES INC (HURA) has a profitability rating of 0 / 10.


What is the earnings growth outlook for TUHURA BIOSCIENCES INC?

The Earnings per Share (EPS) of TUHURA BIOSCIENCES INC (HURA) is expected to grow by 95.06% in the next year.